| Autor: |
Sidwell RW; Institute for Antiviral Research, Utah State University, Logan 84322-5600., Smee DF, Warren RP, Huffman JH, Gilbert BJ, Burger RA, Pearson FC |
| Jazyk: |
angličtina |
| Zdroj: |
Antiviral research [Antiviral Res] 1993 Apr; Vol. 20 (4), pp. 279-92. |
| DOI: |
10.1016/0166-3542(93)90072-q |
| Abstrakt: |
ImuVert, a sterile preparation composed primarily of Serratia marcescens membrane vesicles and ribosomes, was significantly inhibitory to murine cytomegalovirus (MCMV) infections in BALB/c mice. Antiviral activity was manifested as increased survivor number and decreased recoverable virus titers in spleens, lungs and salivary glands. Treatments were intraperitoneal (i.p.) beginning 24 h pre, 4 h post- or 24 h post-virus inoculation and then repeated 4 days later. Doses of 5, 16 or 50 micrograms/mouse were effective; 160 micrograms/mouse, which caused host weight loss in toxicity controls, was not inhibitory to the infection. A single i.p. treatment of mice substantially augmented natural killer (NK) cell activity and increased total B-cells, while reducing total T- and T-helper cells. A late (48 h) decline in T-cell function and transient increases in B-cell function were observed in the treated animals. Serum interferon was not induced. Mice pretreated with anti-asialo GM1 antibody to reduce their NK cell populations, then infected with MCMV and treated with ImuVert were protected to the same degree as normal animals. Severe combined immunodeficient mice infected with MCMV and treated with ImuVert were not protected from the infection. These data suggest ImuVert to act by a mechanism other than NK cell activation in preventing MCMV infections. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
